TB-500
Premium Compound
€32
Whole-body recovery and flexibility support — when systemic repair and bounce-back after hard training is the aim.
Neturime
Specifikacijos
| Forma | Liofilizuotas milteliai |
|---|---|
| Grynumas | >99 % (laboratorijoje testuota) |
| Application | Tik laboratoriniams tyrimams |
Aprašymas
TB-500 appears under All Peptides, Recovery for laboratory use. Confirm the active variation before opening any certificate link shown for it.
Select the option above to view current availability, variation details, and the live price for TB-500.
Show full research details
tb-500 research overview
This page orients researchers to this catalog item within Recovery. Use selector-driven records for variation-specific details rather than static copy alone.
Original catalog notes
TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4 - one of the most-studied recovery peptides, investigated for cell migration, tissue repair and flexibility. Available in 5mg and 10mg.
Why it stands out
- Studied for actin regulation and cellular migration in recovery
- Investigated for soft-tissue, tendon and muscle repair
- Pairs classically with BPC-157 for a complete recovery profile
- Select your dosage below - 5mg or 10mg, lab tested to >99% purity
Supplied as lyophilised powder, >99% purity, lab-tested with a certificate of analysis on every batch. For laboratory and research use only — not for human or animal consumption.
Option records and availability
Variation labels, imagery, and stock for this listing are maintained by WooCommerce selectors. Confirm the active option, then review related items in Recovery.
Documentation expectations
Where certificates are available, review them after choosing the relevant option. Maintain chain-of-custody notes that reference catalog IDs and lot details.
Study planning considerations
Design experiments so observations remain tied to selector-confirmed options. Treat descriptive text as orientation only.
External research references
Indexed publications may mention related research topics. Start with a PubMed literature search for tb-500 for background review. These references are not clinical recommendations.
Storage and research-only scope
Store materials under conditions consistent with label and certificate guidance. Qualified personnel remain responsible for experimental design.
For laboratory and research use only. Catalog copy does not establish safety, efficacy, or suitability for personal use.
Receipt identifiers, selector screenshots, and certificate URLs provide a practical audit trail when multiple catalog items from Recovery are handled in parallel.
Record the date each container is received, inspected, and entered into inventory so later analytical reports can be reconciled with the correct material.
Any variation selected for a study should be documented before preparation begins; changing the selector later does not amend laboratory records already created.
Use calibrated equipment and validated methods appropriate to the planned analysis. Catalog descriptions do not replace method qualification or internal quality controls.
Review the physical label on TB-500 against the order record before assigning an internal sample number.
Keep raw instrument output, preparation notes, and observation logs under the same study identifier to preserve a clear path from source material to reported result.
If a displayed document does not match the selected catalog option, pause the workflow and resolve the discrepancy before opening or preparing the material.
Storage conditions should be monitored according to the label and the laboratory's approved procedures, with deviations recorded in the sample history.
Independent literature can inform study design, but it does not verify the identity of a catalog item; that determination belongs to appropriate analytical testing.
Researchers should distinguish supplier documentation from their own findings and retain both records without presenting one as a substitute for the other.
Dispose of unused material and consumables under the laboratory's applicable procedures rather than relying on general product-page guidance.
Before any analytical run involving TB-500, cross-check certificates, internal sample logs, and preparation checklists maintained by the laboratory.
Research teams in Recovery often archive selector screenshots and COA URLs alongside physical samples for audit trails.
When comparing related listings, prioritize identity confirmation and chain-of-custody notes over descriptive marketing language.
Laboratories should confirm that catalog records, environmental conditions, and instrument readouts remain linked to the same internal sample identifier through storage, preparation, and analysis.
